PhRMA Statement Regarding Prescription Drug User Fee Act Reauthorization

Washington, D.C. (May 24, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today:
 

Counterfeit Medicines: Q&A with Pfizer's Chief Security Officer

05.21.12 | By

The editors at The Catalyst recently asked John P. Clark, Vice President and Chief Security Officer, Pfizer Inc., a few questions about being on the front line in the battle against foreign counterfeit medicines. John provided a snapshot of the risks patients could face if the closed U.S. drug supply system were to open up. I urge you take a close look at all the pictures provided by Pfizer Inc.

Speech: 2012 PhRMA Annual Meeting: President's Address

John J. Castellani
President & CEO
Pharmaceutical Research and Manufacturers of America
Annual Meeting Address
Boston, Massachusetts
April 12, 2012

In our industry today, everyone uses familiar words to describe what we do: Innovation, progress, technology, value, science, partnership, solutions, jobs and so many more.

But to resonate, these words must do more than just describe – they must tell our story.

PhRMA Statement on AARP Drug Pricing Report

Washington, D.C. (March 6, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matt Bennett issued the following statement:

“AARP has released yet another misleading pricing report that ignores key facts about the marketplace for prescription medicines and paints an inaccurate picture of prescription drug spending in the U.S.

PhRMA Statement on State of the Union

Washington, D.C. (January 24, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani released the following statement in response to the President's State of the Union address:

APEC Mexico City Principles for Voluntary Codes of Business Ethics in the Biopharmaceutical Sector

Speech: Remarks of John J. Castellani Before the National Italian American Federation

Thank you, John, for that kind introduction. And thanks also to the National Italian American Foundation for inviting me to take part in this Series of Distinguished Lectures. To be asked to take part in an event that has featured so many Washington men and women whom I admire… It’s a true honor. And it is a pleasure to be speaking to a room full of people whose names also end in a vowel. 
 

PhRMA Statement on Preserving American Jobs, Fostering Innovation

Washington, D.C. (September 7, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani released the following statement today about American jobs:
 

PhRMA Statement on Biosimilars Regulatory Pathway

Washington, D.C. (August 4, 2011) —Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President David E. Wheadon today issued the following statement on the FDA’s ongoing efforts to develop a user fee program and regulatory pathway for biosimilars products:
 
“A perspective piece published today in The New England Journal of Medicine outlines important themes in the ongoing development of an effective and efficient review and approval process for biosimilars.
 

PhRMA Statement on President Obama’s Debt Reduction Speech

Washington, D.C. (April 13, 2011) – Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani today released the following statement:

"PhRMA firmly supports a viable, comprehensive policy framework to cultivate an environment that encourages innovative biopharmaceutical companies to remain and grow in the U.S. And we welcome the opportunity to work with the President and Congress to achieve this shared goal.

Pages

Subscribe to RSS - Opinion